(2020) reported that hepatocyte-specific deletion of Mapk14 in HFD-induced fatty liver exacerbated steatosis and liver injury, indicating Mapk14 plays distinct roles in NAFLD. The gene discussed is MAPK14; the disease is metabolic dysfunction-associated steatotic liver disease.